Getting Pregnant? The Latest Evidence-Based Information Every Woman Needs to Know
![Getting Pregnant? The Latest Evidence-Based Information Every Woman Needs to Know](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_480/images.spreaker.com/original/b002a90be9820fb07af4610df48a0f28.jpg)
Regístrate gratis
Escucha este episodio y muchos más. ¡Disfruta de los mejores podcasts en Spreaker!
Descarga y escucha en cualquier lugar
Descarga tus episodios favoritos y disfrútalos, ¡dondequiera que estés! Regístrate o inicia sesión ahora para acceder a la escucha sin conexión.
Descripción
Get ready for a thought-provoking journey into the world of Multiple Sclerosis and Pregnancy in our latest episode titled"Getting Pregnant? The Latest Evidence-Based Information Every Woman Needs to Know about...
mostra más[SHOW NOTES: MS and Pregnancy - Final Summary]
Here's a comprehensive summary of the key points covered:
- Misinformation Survey (0:02)
- Dr Straukiene discusses a survey revealing that 50% of women with MS receive misinformation about family planning.
- Impact of Pregnancy on MS (5:12)
- Research shows that relapse rates decrease during pregnancy, but there is a rebound of disease activity after delivery.
- Pregnancy may have a significant long-term impact on women with MS, potentially outweighing the impact of disease-modifying therapies.
- MS Treatments During Pregnancy and Postpartum (11:12)
- Research suggests a window of opportunity during pregnancy for reducing long-term disability accumulation.
- Early family planning is encouraged to maximize potential benefits.
- Managing MS during pregnancy, especially in the postpartum period, requires strategic planning to prevent relapses.
- MS Disease-Modifying Therapies During Pregnancy (16:54)
- Consideration of potential risks of disease-modifying therapies during pregnancy is crucial.
- Safety concerns exist for certain therapies, like fingolimod, natalizumab anti CD20 therapies.
- Natalizumab use has risks, including thrombocytopenia for fetus, but can be restarted after delivery with proper coordination.
- Managing MS During Pregnancy and Breastfeeding (25:21)
- A multidisciplinary team, including obstetricians, MS nurses, and consultants, can improve outcomes.
- MS Treatment and Breastfeeding During Postpartum (29:44)
- Breastfeeding can help reduce postpartum disease activity.
- Breastfeeding and Postpartum Relapse Prevention (34:52)
- Exclusive breastfeeding may reduce postpartum relapse risk, but it doesn't completely suppress inflammation.
- Restarting disease-modifying therapy after delivery reduces relapse risk.
- Breastfeeding is safe while on disease-modifying therapy.
- MS, Breastfeeding, and Disease-Modifying Therapies (40:23)
- Research has examined the transfer of disease-modifying therapies in breast milk.
- Practical advice is offered, including storing colostrum and effective communication with healthcare providers.
Vilija also helped to develop this women's health check list, it might also be of interest:
https://www.msplus.org.au/uploads/documents/2023-MS-Plus-Womens-Health-Week-Checklist.pdf
Información
Autor | Dr Agne Straukiene |
Página web | - |
Etiquetas |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company